Kiniksa Pharmaceuticals International, plc KNSA
94.97 USD -3.79 (-3.83%)
Nov 10, 2026, 11:56 AM EST
94.03 Day range 98.37
37.02 52-week range 99.31
- YTD
- +130.24%
- 1 year
- +140.44%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 677.56M | 423.24M | 270.26M | 220.18M | 38.54M | |
| 599.89M | 362.33M | 236.85M | 197.28M | 29.44M | |
| 77.22M | -45.62M | -25.20M | 9.77M | -156.64M | |
| 59.01M | -43.19M | 14.08M | 183.36M | -157.92M | |
| 0.75 | -0.60 | 0.20 | 2.60 | -2.30 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 165.60M | 183.58M | 107.95M | 122.72M | 122.47M | |
| 763.63M | 580.55M | 526.32M | 459.67M | 232.80M | |
| 196.03M | 142.12M | 87.48M | 63.52M | 47.76M | |
| 9.50M | 9.86M | 12.26M | 5.92M | 6.05M | |
| 567.61M | 438.44M | 438.84M | 396.15M | 185.04M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 137.99M | 25.69M | 13.30M | 5.81M | -126.30M | |
| -188.99M | 37.67M | -29.56M | -8.08M | 128.63M | |
| 33.02M | 12.27M | 1.50M | 2.52M | 5.88M | |
| -1.57M | -252.00K | -130.00K | -14.00K | -415.00K | |
| -17.98M | 75.63M | -14.76M | 245.00K | 8.22M |